4-hydroxy-3-(2-(m-tolylamino)thiazol-4-yl)-2H-chromen-2-one

ID: ALA2048092

Chembl Id: CHEMBL2048092

PubChem CID: 54742498

Max Phase: Preclinical

Molecular Formula: C19H14N2O3S

Molecular Weight: 350.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(Nc2nc(-c3c(O)c4ccccc4oc3=O)cs2)c1

Standard InChI:  InChI=1S/C19H14N2O3S/c1-11-5-4-6-12(9-11)20-19-21-14(10-25-19)16-17(22)13-7-2-3-8-15(13)24-18(16)23/h2-10,22H,1H3,(H,20,21)

Standard InChI Key:  GJUDUCDHTQRENV-UHFFFAOYSA-N

Associated Targets(Human)

Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VKORC1 Tclin Vitamin k epoxide reductase complex subunit 1 isoform 1 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.40Molecular Weight (Monoisotopic): 350.0725AlogP: 4.67#Rotatable Bonds: 3
Polar Surface Area: 75.36Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.96CX Basic pKa: CX LogP: 4.38CX LogD: 2.94
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.53Np Likeness Score: -1.09

References

1. Mladenović M, Mihailović M, Bogojević D, Vuković N, Sukdolak S, Matić S, Nićiforović N, Mihailović V, Mašković P, Vrvić MM, Solujić S..  (2012)  Biochemical and pharmacological evaluation of 4-hydroxychromen-2-ones bearing polar C-3 substituents as anticoagulants.,  54  [PMID:22633008] [10.1016/j.ejmech.2012.04.036]

Source